Want to join the conversation?
$HSIC 2Q15 Call: Operating cash flow for the quarter was $207.8MM, up from $199.2MM in last year second quarter. We continued to believe that we will have strong operating cash flow for the full year. Our accounts receivable days sales improved slightly to 39.3 days compared to 40.2 days last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.